Solid Biosciences's total assets for Q2 2025 were $308.29M, a decrease of -10.36% from the previous quarter. SLDB total liabilities were $50.00M for the fiscal quarter, a 1.13% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.